CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: CFI-402257|DRUG: Paclitaxel
Sponsor: Canadian Cancer Trials Group
Collaborators: Stand Up To Cancer|Canadian Breast Cancer Foundation|Ontario Institute for Cancer Research